Actividad inhibidora de la enzima convertidora de la angiotensina de un hidrolizado de lactosuero de cabra con proteasa de Aspergillus oryzae
Angiotension-converting enzyme inhibitory activity of goat whey hydrolyzed with Aspergillus oryzae protease
| dc.creator | Alvarado, Carlos | |
| dc.creator | Gómez-Ruiz, José | |
| dc.creator | Guerra, Marisa | |
| dc.date | 2013-10-23T21:13:25Z | |
| dc.date | 2013-10-23T21:13:25Z | |
| dc.date | 2013-10-23 | |
| dc.date.accessioned | 2022-10-28T00:55:27Z | |
| dc.date.available | 2022-10-28T00:55:27Z | |
| dc.identifier | 11120116313779 | |
| dc.identifier | http://hdl.handle.net/10872/4612 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4938895 | |
| dc.description | The purpose of this research was to determine the inhibitory activity of the Angiotensin-converting enzyme (ACE) of a goat whey hydrolysate obtained by application of an Aspergillus oryzae protease/peptidase complex (Flavourzyme). Goat cheese whey was hydrolyzed under controlled conditions, considering two variables: whey protein concentration method (ultrafiltration and thermo-coagulation) and inclusion or not of an acid lactic bacteria in the enzymatic treatment. Hydrolysate derived from the combined action of acid lactic bacteria and the protease on the thermo-coagulated whey proteins showed the largest ACE inhibitory activity. It is concluded that this technique might allow using goat whey as a functional ingredient in the prevention of hypertension. | |
| dc.description | CDCH proyecto de grupo PG-11-7132-2008/1 | |
| dc.language | es | |
| dc.subject | goat whey | |
| dc.subject | Aspergillus oryzae | |
| dc.subject | angiotensin-converting enzyme | |
| dc.title | Actividad inhibidora de la enzima convertidora de la angiotensina de un hidrolizado de lactosuero de cabra con proteasa de Aspergillus oryzae | |
| dc.title | Angiotension-converting enzyme inhibitory activity of goat whey hydrolyzed with Aspergillus oryzae protease | |
| dc.type | Article |